Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Gyöngyösi Adrienn

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2008-2025

2025

Gyöngyösi, A., Korpos, É., Kállai, J., Lányi, Á.: A mieloid eredetű szuppresszor sejtek szerepe a tumor mikrokörnyezetben, terápiás lehetőségek.
Immunol. Szle. 17 (1), 34-43, 2025.

DEA

2023

Szántó, G. T., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
Pharmaceuticals (Basel). 16 (5), 1-15, (article identifier: 656), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

Cozzolino, M., Gyöngyösi, A., Korpos, É., Gogolák, P., Naseem, M. U., Kállai, J., Lányi, Á., Panyi, G.: The Voltage-Gated Hv1 H<U+009a> Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells.
Int. J. Mol. Sci. 24 (7), 1-24, (article identifier: 6216), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2019

Markovics, A., Tóth, K. F., Sós, K., Magi, J., Gyöngyösi, A., Benyó, Z., Zouboulis, C. C., Bíró, T., Oláh, A.: Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2).
J. Cell. Mol. Med. 23 (9), 6203-6214, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q1 Molecular Medicine

2018

Oláh, A., Markovics, A., Tóth, K. F., Sós, K., Magi, J., Gyöngyösi, A., Benyó, Z., Zouboulis, C. C., Bíró, T.: Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2).
J. Invest. Dermatol. 138 (5), S224, 2018.

DEA WoS

Markovics, A., Tóth, K. F., Sós, K., Magi, J., Gyöngyösi, A., Benyó, Z., Zouboulis, C. C., Bíró, T., Oláh, A.: Sebaceous lipogenesis of human sebocytes is suppressed by nicotinic acid via the activation of hydroxycarboxylic acid receptor 2 (HCA2).
Exp. Dermatol. 27 (Suppl.), 27, 2018.

doi DEA WoS

2014

Dócs, O., Gyöngyösi, A., András, C., Bálint, L. B., Horváth, Z., Méhes, G.: A miR-92a a PTEN gátlása által módosíthatja a rosszindulatú vastagbélrákos betegek túlélését.
Klinikai Onkológia. 1 (Suppl.), 23, 2014.

DEA

Gyöngyösi, A., Dócs, O., Czimmerer, Z., Orosz, L., Horváth, A., Török, O., Méhes, G., Nagy, L., Bálint, B. L.: Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffin-embedded samples.
In: RNA Mapping : Methods and Protocols . Ed.: M. Lucrecia Alvarez, Mahtab Nourbakhsh, Humana Press, New York, 105-119, 2014. ISBN: 9781493910618(Print)9781493910625(Online)

doi DEA

Dócs, O., Gyöngyösi, A., Fazakas, F., Beke, L., Bálint, B. L., András, C., Horváth, Z., Méhes, G.: MiR-92a potentially modulates survival of metastatic colorectal carcinoma patients via PTEN signalization.
Virchows Arch. 465, 321, 2014.

DEA

2013

10.

Gyöngyösi, A., Szatmári, I., Pap, A., Dezső, B., Pos, Z., Széles, L., Varga, T., Nagy, L.: RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.
J. Lipid Res. 54 (9), 2458-2474, 2013.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Endocrinology

2012

11.

Tsakiris, I., Töröcsik, D., Gyöngyösi, A., Dózsa, A., Szatmári, I., Szántó, A., Soós, G., Nemes, Z., Igali, L., Márton, I., Takáts, Z., Nagy, L., Dezső, B.: Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.
Lab. Invest. 92 (3), 345-361, 2012.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q2 Molecular Biology

D1 Pathology and Forensic Medicine

2011

12.

Nakken, B., Varga, T., Szatmári, I., Széles, L., Gyöngyösi, A., Illarionov, P. A., Dezső, B., Gogolák, P., Rajnavölgyi, É., Nagy, L.: Peroxisome proliferator-activated receptor [gamma]-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.
J. Immunol. 187 (1), 240-247, 2011.

doi DEA

Journal metrics:

D1 Immunology

2008

13.

Gyöngyösi, A., Nagy, L.: Potential Therapeutic Use of PPAR[gamma]-Programed HumanMonocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.
PPAR Research. 2008, [1-10], 2008.

doi DEA